AGENUS Trademark

Serial Number: 97886578

AGENUS is a trademark filed by Agenus Inc. on April 13, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Agenus Inc. (42 trademarks)

3 Forbes Road
Lexington, MA 02421

Entity Type: 03

Legal Representation

Attorney of Record

CHRISTINA M LICURSI

4 trademarks filed View all →

Correspondence Address

CHRISTINA M LICURSI WOLF GREENFIELD & SACKS PC

600 ATLANTIC AVENUE

BOSTON, MA 02210-2206

UNITED STATES

Trademark Details

Filing Date

April 13, 2023

Registration Date

Not Registered

First Use Anywhere

January 6, 2011

First Use in Commerce

January 6, 2011

Goods & Services

Pharmaceutical research and development; scientific research and development; medical research and development; pharmaceutical research and development in the fields of cancer, immunology, and immuno-oncology

Biological preparations for scientific and research purposes; monoclonal antibodies for scientific and research purposes; antibodies for scientific and research purposes

Therapeutic pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biologics for medical purposes, namely, biological preparations for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; monoclonal antibodies for medical purposes; antibodies for medical purposes; adjuvants for medical purposes; vaccines; cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease